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Abstract
Background: Some studies have analyzed the association of health care systems variables, such as health service
resources or expenditures, with amenable mortality, but the association of types of health care systems with the
decline of amenable mortality has yet to be studied. The present study examines whether specific health care
system types are associated with different time trend declines in amenable mortality from 2000 to 2014 in 22
European OECD countries.
Methods: A time trend analysis was performed. Using Nolte and McKee’s list, age-standardized amenable mortality
rates (SDRs) were calculated as the annual number of deaths over the population aged 0–74 years per 100,000
inhabitants. We classified health care systems according to a deductively generated classification by Böhm. This
classification identifies three dimensions that are not entirely independent of each other but follow a clear order:
the regulation dimension is first, followed by the financing dimension and finally service provision. We performed
a hierarchical semi-log polynomial regression analysis on the annual SDRs to determine whether specific health
care systems were associated with different SDR trajectories over time.
Results: The results showed a clear decline in SDRs in all 22 health care systems between 2000 and 2014 although at
different annual changes (slopes). Regression analysis showed that there was a significant difference among the slopes
according to provision dimension. Health care systems with a private provision exhibited a slowdown in the decline of
amenable mortality over time. It therefore seems that ownership is the most relevant dimension in determining a
different pattern of decline in mortality.
Conclusions: All countries experienced decreases in amenable mortality between 2000 and 2014; this decline
seems to be partially a reflection of health care systems, especially when affected by the provision dimension. If
the private ownership is maintained or promoted by health systems, these findings might be considered when
thinking about regulation policies to control factors that might influence health care performance.
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Background
Amenable mortality is defined as premature death from
a set of conditions that should not occur in the presence
of timely and effective health care [1].
Adequate health care may prevent mortality due to a
variety of causes by means of preventive or therapeutic
measures [2].
This concept was originally developed by Rutstein et al.,
who created a list of conditions that were considered
either treatable or preventable based on current medical
knowledge and technology [3]. Subsequently, the concept
of amenable mortality was explored widely, especially in
Europe [4–7] and has been adopted as an indicator of
the performance of health care systems by organiza-
tions such as the England Department of Health [8]
and the Organisation for Economic Cooperation and
Development (OECD) [8].
Levels and trends of amenable mortality have been
widely documented [2, 9–13]. Most researchers have
shown that levels of amenable mortality have substantially
decreased over the past years. Nolte and McKee [2] con-
ducted a comprehensive study in 19 OECD countries
between 1997/1998 and 2002/2003 and found a reduction
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in amenable mortality in all countries. The average re-
duction rate was 14% in females and 17% in males.
More recently, Gay et al. [9] measured the average
annual change in amenable mortality in 31 OECD
countries between 1997 and 2007 and concluded that
amenable mortality declined in all OECD countries; the
average annual decline was 3.7%.
Some studies have analyzed the associations of health
care systems variables, such as health service resources
[7] or expenditures, with amenable mortality [14], but
the association of types of health care systems with the
decline of amenable mortality has yet to be studied.
The present study builds on the aforementioned find-
ings and examines whether specific health care system
types are associated with different time trend declines in
amenable mortality from 2000 to 2014. The study in-
cludes 22 OECD European countries that are associated
with different types of health care systems.
Methods
A time trend analysis was performed using secondary
data from 22 European OECD countries during the
period 2000 to 2014.
The mortality and population data for this study came
primarily from the World Health Organization (WHO)
Mortality Database [15], in which causes of death are
coded according to the ICD-9 or ICD-10. If reference
populations were not available in the WHO Mortality
Database, the data were extracted from the 2012 Revi-
sion of the World Population Prospects (WPP) [16] (see
Additional file 1 for the list of countries included in the
study).
Nolte and McKee [2, 17, 18] and Tobias and Yeh [19]
prepared two different lists of causes of death that are
amenable to health care. These two lists were used by
the OECD to generate estimates of amenable mortality
for 31 countries [9]. After reviewing the two sets of esti-
mates of amenable mortality for the OECD countries
provided by Nolte and McKee’s and Tobias and Yeh’s
lists, we decided to choose Nolte and McKee’s because it
provides, on average, more conservative figures (see
Additional file 2, which includes Nolte and McKee’s list
of causes of death amenable to health care).
Many health care system classifications exist. We adopted
the typology that was presented by Rothgang and Wendt
[20, 21] and modified by Böhm [22] because it attempts a
deductive construction of health care system types and
allows for a more precise classification of health care
systems. The health care system is defined by three di-
mensions that are not entirely independent of each other
but follow a clear order: the regulation dimension is first,
followed by the financing dimension and finally service
provision. In every dimension, three actors can play a role:
state, societal or private actors (see Additional file 3 for a
summary of Böhm’s classification) [22].
For each country, age-standardized amenable mortality
rates (amenable SDRs) were calculated as the annual
number of deaths in the population aged 0–74 years per
100,000 inhabitants, with direct standardization to the
2010 OECD population. First, the data were summarized
by presenting the average annual amenable SDRs for the
years 2000/2001 and 2013/2014 and by computing the
percentage change in amenable SDRs between these time
periods. Second, we performed a hierarchical semi-log poly-
nomial regression model analysis on the annual amenable
SDRs, with random intercepts and slopes to take into
account individual heterogeneity across countries. In
this model, we applied a log transformation of amen-
able SDR to ease interpretability of results (the regres-
sion slope is equal to the annual percentage change in
amenable SDR) and to improve the model fit, since de-
scriptive analysis had revealed a convex, exponential trend
over time. Nevertheless, we decided to add the squared
term of year to the log-linear model because the linearity
assumption, checked through a joint Wald test on dum-
mies for all years, appeared to be violated (F-test = 3.21,
P = 0.003). The model included also the three health
care system dimensions and their interaction with year
and year-squared to determine whether specific health
care systems were associated with different amenable
SDR trajectories over time. Because of the limited number
of countries included in the study (n = 22), standard
errors for both fixed- and random-effects parameters
were estimated using cluster bootstrapping with 1000
replicates.
For all analyses, the significance level was set at P < 0.05.
All data were analyzed using the Stata software package,
version 13 (StataCorp. 2013. Stata Statistical Software:
Release 13. College Station, TX, USA: StataCorp LP).
Results
Figure 1 displays the amenable SDRs from all causes per
100,000 persons in all 22 countries examined. All countries
experienced decreases in amenable mortality between 2000
and 2014, with some relevant differences. Eastern European
countries (Czech Republic, Estonia, Hungary, Poland,
Slovakia) exhibited disharmonious declines and differed
with a wider range of initial and final mortality rates.
The other European countries exhibited small within-
region differences in the reduction of amenable SDRs.
Table 1 shows amenable SDRs from all causes for the
years 2000/2001 and 2013/2014. Between 2000/2001 and
2013/2014, mortality rates decreased by between approxi-
mately 30 and 45% in all countries. Table 1 also shows the
distribution of the three health care system dimensions:
8 countries had statal regulation, financing and provision
(Denmark, Finland, Iceland, Norway, Portugal, Spain,
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Sweden, United Kingdom), while other 8 countries
had statal regulation, societal financing and private
provision (Belgium, Czech Republic, Estonia, France,
Hungary, Netherlands, Poland, Slovakia); of the remaining
6 countries, three had societal regulation, societal financing
and private provision (Austria, Germany, Luxembourg),
two had statal regulation, statal financing and private
provision (Ireland, Italy) and one, Slovenia, had societal
regulation, societal financing and statal provision.
Results of regression analysis are presented in Table 2.
The downward trend of amenable SDRs, equal to 4% per
year, was significant (b = −0.040; 95% CI = −0.043, −0.037;
P < 0.001) and differed among the three dimensions under
study: in countries with societal regulation, statal financing
and private service provision the curvilinear (U-shaped)
trend was more pronounced than in countries with statal
regulation, societal financing and statal provision, respect-
ively (regulation: b = 0.001; 95% CI = < 0.001, 0.002;
P = 0.010; financing: b = −0.001; 95% CI = −0.002, −0.001;
P < 0.001; provision: b = 0.001; 95% CI = 0.001, 0.002;
P < 0.001). Of note, the standard deviation of random
intercepts was significant [SD(Country) = 0.293; 95%
CI = 0.189, 0.454; P < 0.001], indicating that the vari-
ables included in the model explain only part of the
differences in SDRs among countries.
Results of this regression analysis are also illustrated in
Fig. 2, where mortality rates estimates are stratified by
dimension and plotted for each year. Countries with
societal regulation and statal financing had a pro-
nounced slowdown in the reduction of amenable SDRs,
but came also from low mortality levels and had pre-
sumably less room for improvement during the study
period (Fig. 2a and b). The same cannot be said for
countries with private provision, whose amenable SDRs
at the beginning of the observation period did not signifi-
cantly differ from those of countries with statal provision.
Discussion
This study aimed to examine whether specific health care
system types are associated with different patterns of de-
cline in amenable mortality from 2000 to 2014 in 22 OECD
European countries.
Due to the absence of any accepted or authoritative
taxonomy of health care systems, we had to make a
choice. The most used classification by researchers is
OECD classification. This classification is based on the
extent of coverage, mode of financing and delivery of
health care, and distinguishes among three types of
health systems: National Health Service (NHS), social
health insurance (SHI) and the private health insurance
(PHI). The NHS model combines universal coverage
with funding from general tax revenue. Delivery is char-
acterized by public ownership. The SHI model features
universal coverage, and it is funded mainly by contribu-
tions and public or private delivery. Finally, in the PHI
model, coverage is based on private insurance only,
which is also the major funding source, and private own-
ership of the health infrastructure.
As highlighted by some authors, the standard trichot-
omous classification of health systems into national health
Fig. 1 Amenable age-standardized death rates from all causes (per 100,000 people) for 0–74 year olds in 22 OECD European countries (2000 to
2014). Note: Missing data within the time-series of Italy (2004, 2005) and Portugal (2004–2006) were interpolated by connecting the lines between
the non-missing data points. Abbreviations: SDR, age-standardized death rate; AUT, Austria; BEL, Belgium; CZE, Czech Republic; DEU, Germany;
DNK, Denmark; EST, Estonia; FIN, Finland; FRA, France; HUN, Hungary; IRL, Ireland; ISL, Iceland; ITA, Italy; LUX, Luxembourg; NDL, Netherlands; NOR,
Norway; POL, Poland; PRT, Portugal; SVK, Slovakia; SVN, Slovenia; ESP, Spain; SWE, Sweden; GBR, United Kingdom
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Table 2 Results of hierarchical semi-log polynomial regression models on amenable age-standardized death rates from all causes
(per 100,000 persons) in 22 OECD European countries (2000 to 2014)
Variable Regression Bootstrap P Normal-based
coefficient (b) standard error 95% CI
Year −0.040 0.002 <0.001 −0.043, −0.037
Year2 <0.001 <0.001 0.538 > − 0.001, 0.001
Societal regulation (ref. Statal) −0.420 0.179 0.019 −0.732, −0.040
Societal financing (ref. Statal) 0.505 0.206 0.014 0.092, 0.865
Private provision (ref. Statal) −0.085 0.123 0.493 −0.306, 0.186
Societal regulation × Year −0.003 0.004 0.467 −0.011, 0.004
Societal financing × Year 0.003 0.007 0.708 −0.010, 0.017
Private provision × Year 0.002 0.007 0.807 −0.012, 0.012
Societal regulation × Year2 0.001 <0.001 0.010 <0.001, 0.002
Societal financing × Year2 −0.001 <0.001 <0.001 −0.002, −0.001
Private provision × Year2 0.001 <0.001 <0.001 0.001, 0.002
Constant 4.393 0.053 <0.001 4.295, 4.506
Random-effects parameters
SD(Country-year) 0.026 0.005 <0.001 0.018, 0.039
SD(Country) 0.293 0.065 <0.001 0.189, 0.454
SD(Year) 0.006 0.002 <0.001 0.003, 0.010
SD(Year2) <0.001 0.002 0.505 n/a
Abbreviations: SDR, age-standardized death rate; 95% CI, 95% confidence interval; SD, standard deviation; n/a, not available
Notes: The quadratic term, year2, indicates the presence of a curvilinear (or nonlinear, U-shaped) trend over time. When year2 is positive and the linear term or
slope, year, is negative, the trend is decreasing and slightly convex. The interaction terms (marked with the sign “×”) indicate how much year and year2 are differ-
ent for different health care system types. So, year and year2 represent the linear and quadratic slope when regulation, financing and provision are issued by pub-
lic actors, i.e., the reference category for each dimension. To obtain the linear decline in amenable SDRs for, say, countries with a societal regulation system, it is
necessary to add the slope and the corresponding interaction term (−0.040–0.003 = −0.043). The exponential of the last term, constant, represents the average
amenable SDR value for countries with public regulation, financing and provision (e4.393 = 88.88)
Fig. 2 Estimated annual change in amenable age-standardized death rates (per 100,000 people) from all causes, stratified by type of regulation
(a), financing (b) and provision (c) (2000 to 2014). Abbreviations: SDR, age-standardized death rate
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services, social insurance systems and private insurance
systems shows inherent weaknesses [23]. There are four
reasons for these weaknesses. First, this classification into
three ideal types is inadequate to properly describe all
health systems because there is a tendency of convergence
from distinct types toward mixed types of health care
systems [20, 24]. Second, and consequently, the extent
of coverage is not a variable that connotes health care
systems because most European countries have achieved
universal (or near-universal) coverage of health care
[25, 26]. Third, this sort of classification is binary: a
case is deemed either to belong to a specified category,
or it is not. However, a set of binary decisions is reduced
to one as a result of the priority given to the financing
mode. Lastly, an effect of the specific attention paid to
financing is the relative paucity of attention given to the
matter of regulation [23].
In addition to these reasons, other reasons justify why
we chose the classification proposed by Böhm [22]. The
first reason for choosing Böhm’s classification was the
presence of multiple dimensions (Regulation, Financing
and Provision). Second, the classification provided a de-
ductive approach to build the classification that overtakes
the inductive approach, which is more or less closely re-
lated to a sample of real cases of health care systems [22].
Third, the health care sectors for this classification were
weighted in the provision dimension (typically inpatient
care, outpatient care and pharmaceuticals), which better
combines with the concept of amenable mortality. In the
present study, we found a clear decline in amenable SDRs
in all 22 European health care systems between 2000 and
2014, although this decline occurred at different annual
changes (or slopes). This result is consistent with previous
studies and confirms that previously documented trends
are continuing up to 2014 [2, 27–29].
The hierarchical regression model showed that there
was a significant difference between slopes according to
the provision dimension, and this result could not be
ascribable to different levels of mortality at the begin-
ning of the study period as opposed to the other two di-
mensions. Health care systems with a private provision
exhibited a slowdown in the decline of amenable mortal-
ity over time. It therefore seems that, among the three
dimensions here considered, ownership is the relevant in
determining a different pattern of mortality reduction.
This finding suggests that private for-profit providers
are not able to achieve additional gains in the determinants
of health care improvements. These determinants include
the innovation and speed of their implementation as well as
the quality of care and health care coverage [13]. This inter-
pretation gains some support from conclusions of previous
studies, which note that there is little evidence to support
that private for-profit providers will increasingly adopt
levels of innovation and technologies. Indeed, private for-
profit providers may have fewer resources to spend on care
because of taxes and their over-emphasized cost control,
which aims to achieve the highest possible return on invest-
ment. Consequently, this can result in less qualified staff
and/or less investment on equipment or technology
and can negatively impact health care related performance
[30, 31]. Moreover, this interpretation is confirmed by the
results of systematic reviews. Some authors [31, 32] found
that the private for-profit ownership of hospitals, in com-
parison with private non-profit and public ownership of
hospitals, results in a higher risk of death for patients and
worst results on health outcomes.
Our study has strengths and weaknesses. Some studies
have tried to find some relationship between health care
resources or expenditure and amenable mortality. We
examined whether different time trends in amenable mor-
tality were associated with health care system type and
found a relationship with the provision dimension. These
findings must be interpreted very carefully; they do not
suggest the superiority for one model of ownership over
other. Instead, if the private for-profit ownership is main-
tained or promoted by health systems, these results might
be considered when thinking about regulation policies
that could diminish or control the negative consequences.
Of note, we investigated whether the mortality decline,
and not the average amenable SDR values calculated
over the study period, was affected by the three dimensions.
This is why a significant difference among the average
amenable SDRs by dimension can be biased by confound-
ing factors such as national mortality levels.
The main weakness of this study is that this analysis has
been conducted at the health systems dimensions level and
has not disaggregated Financing, Regulations and Provision
by country. Thus, findings showed that countries with pri-
vate provision have seen a slowdown in the decline in
mortality rates in comparison with countries with statal
provision, but findings can conceal potential variation in the
rate of decline among the 22 European countries. Conse-
quently, analysis at the national level must be conducted to
assist policymakers to make better-informed decisions about
arrangements within providers in health care systems.
Second, the type of classification accounts for the regu-
lation dimension which has remained a largely under-
explored aspect of health care system [33].
However, for classifying the regulation dimension the
basic question is “who is in charge of regulating and con-
trolling these relationships?” but on its own it cannot ex-
plain the modes of interaction for each object in a given
country. Consequently, specific aspects such as evaluation
of compliance to quality standards into regulation of ac-
cess of (potential) providers to health care markets (see
Additional file 3) are not accounted for. These aspects
may have explanatory power on level and trend of amen-
able mortality.
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Conclusion
This study, which is based on a time trend analysis, is an
explorative research on association between specific health
care systems with different SDR trajectories over time.
The main findings of our study show that the declin-
ing trend of amenable mortality rates is continuing in
2013/2014 in 22 European countries and that the decline
in amenable mortality seems to be partially a reflection
of health care systems, especially when affected by the
provision dimension: countries with private provision
saw a slowdown in the decline of mortality rates.
These findings are a source of inspiration to stimulate
further researches with lower aggregated data that could
overcome the limitations of this study and suggest that
monitoring and evaluating the ownership of health care
providers should always be considered in order to better
understand the effect of one or other type of ownership.
If the private ownership is maintained or promoted by
health systems, these findings might be considered when
thinking about regulation policies to control factors that
might influence health care performance.
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